Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (20)

2023

  1. End-on PEGylation of heparin: Effect on anticoagulant activity and complexation with protamine

    International Journal of Biological Macromolecules, Vol. 249

2020

  1. Design of polymeric nanocapsules for intranasal vaccination against mycobacterium tuberculosis: Influence of the polymeric shell and antigen positioning

    Pharmaceutics, Vol. 12, Núm. 6

2019

  1. The size and composition of polymeric nanocapsules dictate their interaction with macrophages and biodistribution in zebrafish

    Journal of Controlled Release, Vol. 308, pp. 98-108

2018

  1. Bilayer polymeric nanocapsules: A formulation approach for a thermostable and adjuvanted E. coli antigen vaccine

    Journal of Controlled Release, Vol. 286, pp. 20-32

  2. Polymeric nanocapsules for vaccine delivery: Influence of the polymeric shell on the interaction with the immune system

    Frontiers in Immunology, Vol. 9, Núm. APR

  3. Protamine Nanocapsules for the Development of Thermostable Adjuvanted Nanovaccines

    Molecular Pharmaceutics, Vol. 15, Núm. 12, pp. 5653-5664

2017

  1. Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers

    Scientific Reports, Vol. 7

2016

  1. Characterization of a monoclonal antibody directed against Mytilus spp larvae reveals an antigen involved in shell biomineralization

    PLoS ONE, Vol. 11, Núm. 3

2015

  1. Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes

    Clinical and Experimental Immunology, Vol. 180, Núm. 2, pp. 207-217

  2. Heparin-Engineered Mesoporous Iron Metal-Organic Framework Nanoparticles: Toward Stealth Drug Nanocarriers

    Advanced Healthcare Materials, Vol. 4, Núm. 8, pp. 1246-1257

  3. In situ nanofabrication of hybrid PEG-dendritic-inorganic nanoparticles and preliminary evaluation of their biocompatibility

    Nanoscale, Vol. 7, Núm. 9, pp. 3933-3940

  4. Multi-enveloping of particulated antigens with biopolymers and immunostimulant polynucleotides

    Journal of Drug Delivery Science and Technology, Vol. 30, pp. 424-434

  5. Protamine-based nanoparticles as new antigen delivery systems

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 97, pp. 51-59

2014

  1. Highly versatile immunostimulating nanocapsules for specific immune potentiation

    Nanomedicine, Vol. 9, Núm. 15, pp. 2273-2289

2013

  1. A Polymer/Oil Based Nanovaccine as a Single-Dose Immunization Approach

    PLoS ONE, Vol. 8, Núm. 4

  2. Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: A needle-free vaccination strategy

    Journal of Controlled Release, Vol. 172, Núm. 3, pp. 773-781

2011

  1. Direct surface plasmon resonance immunosensor for in situ detection of benzoylecgonine, the major cocaine metabolite

    Biosensors and Bioelectronics, Vol. 26, Núm. 11, pp. 4423-4428

  2. Galectin-1 synthesis in type 1 diabetes by different immune cell types: Reduced synthesis by monocytes and Th1 cells

    Cellular Immunology, Vol. 271, Núm. 2, pp. 319-328

2010

  1. Autoantibodies to glial fibrillary acid protein and S100β in diabetic patients

    Diabetic Medicine, Vol. 27, Núm. 2, pp. 246-248

  2. Chitosan-based nanoparticles for improving immunization against hepatitis B infection

    Vaccine, Vol. 28, Núm. 14, pp. 2607-2614